Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2014
04/09/2014CN103709122A Antitumor and antifungal compound for treatment
04/09/2014CN103709093A Combined-ring-containing pleuromutilin antibiotics
04/09/2014CN102781932B Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
04/09/2014CN102516233B Method for producing voriconazole
04/09/2014CN102432558B Method for synthesizing irbesartan and intermediate thereof
04/09/2014CN102276586B Preparation methods of losartan potassium and preparation thereof
04/09/2014CN102026961B 酰胺化合物 Amide compounds
04/09/2014CN101663283B Quinoxaline compounds and use thereof
04/08/2014US8692000 Phase transfer catalysts
04/08/2014US8691999 Process for the preparation of telmisartan
04/08/2014US8691856 Glucagon receptor antagonists, preparation and therapeutic uses
04/08/2014US8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
04/08/2014US8691815 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
04/08/2014US8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/08/2014US8691804 Azetidines and cyclobutanes as histamine H3 receptor antagonists
04/08/2014US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
04/08/2014CA2563607C 4,5-disubstituted-2-aryl pyrimidines
04/08/2014CA2538315C Matrix metalloproteinase inhibitors
04/03/2014WO2014051165A1 Tetrazolinone compounds and their use as pesticides
04/03/2014WO2014051161A1 Tetrazolinone compounds and their use as pesticides
04/03/2014WO2014051008A1 Deprotection method for tetrazole compound
04/03/2014WO2014051004A1 Material for organic electroluminescent elements, and organic electroluminescent element
04/03/2014WO2014050446A1 Pigment composition, colored curable composition, color filter for solid-state imaging element, method for producing same, solid-state imaging element, pigment dispersion composition, method for producing same, and compound
04/03/2014WO2014050084A1 Novel phenylacetamide compound and pharmaceutical containing same
04/03/2014WO2014049047A1 Substituted sulfonamide compounds
04/03/2014WO2014048532A1 Quinazolinone derivatives as parp inhibitors
04/03/2014WO2014048165A1 Compound as potassium channel modulator
04/03/2014WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors
04/03/2014WO2013053983A8 Protein kinase inhibitors
04/03/2014US20140094608 Modified carbocyanine dyes and their conjugates
04/03/2014US20140094480 Pro-Neurogenic Compounds
04/03/2014US20140094474 Androgen receptor modulating carboxamides
04/03/2014US20140094471 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
04/03/2014US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors
04/03/2014US20140094456 Anti-fibrotic pyridinones
04/03/2014US20140094450 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
04/03/2014US20140094436 Imidazole compounds that modulate hsp90 activity
04/03/2014US20140093585 Parp inhibitors for the treatment of cipn
04/03/2014US20140093513 Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9)
04/02/2014EP2712863A1 Novel inhibitors of bacterial biofilms and related methods
04/02/2014EP2712861A1 Thioacetate compounds, compositions and methods of use
04/02/2014EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
04/02/2014EP2712291A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods
04/02/2014CN103702993A Benzamides
04/02/2014CN103702983A Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
04/02/2014CN103694276A Dicarbazolyl derivative, preparation method and application of dicarbazolyl derivative, and electroluminescent device
04/02/2014CN103694227A Erlotinib derivative, and preparation method and application thereof
04/02/2014CN103694163A Compounds capable of being adopted as potassium channel modulators
04/02/2014CN102827246B Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof
04/02/2014CN102712623B Hepatitis c virus inhibitors
04/02/2014CN102438996B Histone deacetylase inhibitors with branched structure synthesized through click chemistry
04/02/2014CN102212058B Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
04/02/2014CN102146215B Pentamethylcyanine fluorescent dye and preparation method and application thereof
04/02/2014CN101939314B Polymorphic forms of a 3-pyrrole substituted 2-indolinone
04/01/2014US8686156 Thiazole derivatives as pesticides
04/01/2014US8686155 Aurora kinase modulators and method of use
04/01/2014US8686145 Process for the preparation of α-acyloxy β-formamido amides
04/01/2014US8686143 Compounds useful as inhibitors of Janus kinases
04/01/2014US8686136 Apoptosis promoters
04/01/2014US8685976 Cell adhesion promoting agent and method of promoting cell adhesion
04/01/2014US8685959 Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
04/01/2014US8685664 Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease
04/01/2014US8685543 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
04/01/2014CA2737299C Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof
04/01/2014CA2619919C Diaminopyrimidines as p2x3 and p2x2/3 modulators
04/01/2014CA2604967C Pyrimidine derivatives and their use as p2y12 receptor antagonists
03/2014
03/27/2014WO2014046544A1 Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators
03/27/2014WO2014046392A1 Organic compound and electroluminescent element having same
03/27/2014WO2014046352A1 Organic light-emitting compound and organic electroluminescent device using same
03/27/2014WO2014046125A1 Prevention/treatment agent for pulmonary hypertension comprising thrombin receptor antagonist as active component
03/27/2014WO2014045310A1 Pyrimido[5,4-d]pyrimidine or pyrimidine derivatives compounds and uses thereof in the treatment of cancer
03/27/2014WO2014045029A1 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
03/27/2014WO2014044755A1 4-(indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer
03/27/2014WO2014044754A1 4-indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer
03/27/2014WO2014044738A1 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
03/27/2014US20140088112 Alkyne benzotriazole derivatives
03/27/2014US20140088106 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/27/2014US20140088103 (fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
03/27/2014US20140088102 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
03/27/2014US20140088097 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
03/27/2014US20140088094 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
03/27/2014US20140088071 sGC STIMULATORS
03/27/2014US20140088029 Novel pyrazole derivative
03/27/2014US20140086834 New i-arylpiperazinic ligands of 5-ht7 receptor and use thereof
03/26/2014EP2711365A1 4-Indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer
03/26/2014EP2711364A1 4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer
03/26/2014EP2710007A2 Kinase inhibitors
03/26/2014EP2709997A1 Inhibitors of bruton's tyrosine kinase
03/26/2014EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators
03/26/2014CN103664936A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664909A Bicarbazole derivative, preparation method, application and organic light-emitting device
03/26/2014CN103664908A Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity
03/26/2014CN103664907A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664906A 6, 6-dimethyl-6H- benzo [cd] pyrene derivative and application thereof
03/26/2014CN103664905A Tandospirone hydrochloride crystal form II and preparation method thereof
03/26/2014CN103664904A Gamma-secretase inhibitor and use thereof
03/26/2014CN103664903A Benzoazepine compounds and preparation method and application thereof
03/26/2014CN103664902A Imidazoline benzotriazole, and derivative, synthesis technology and application thereof
03/26/2014CN103664901A Novel preparation method for rizatriptan benzoate
03/26/2014CN103664900A Novel method for preparing rizatriptan benzoate
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 626